On the other hand, in the whole blood samples, ISG56 was significantly downregulated in both hospitalized COVID-19 patient cohorts, in accordance with previous reports on the downregulation of IFN-1 signaling by SARS-CoV-2 [75,76]. The gene discussed is IFIT1; the disease is COVID-19.